Doxapram for the prevention and treatment of apnea in preterm infants.

Author: AvdicEma, BruschettiniMatteo, EvansShannon, FianderMichelle, PessanoSara, SollRoger

Paper Details 
Original Abstract of the Article :
Apnea of prematurity is a common problem in preterm infants that may have significant consequences on their development. Methylxanthines (aminophylline, theophylline, and caffeine) are effective in the treatment of apnea of prematurity. Doxapram is used as a respiratory stimulant in cases refractory...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598592/

データ提供:米国国立医学図書館(NLM)

Apnea in Preterm Infants: A Desert Oasis of Doxapram

The study explores the realm of preterm infants, where the delicate balance of breathing can be precarious. Like a desert oasis providing vital sustenance, Doxapram emerges as a potential lifeline for preterm infants struggling with apnea. This research examines the potential benefits of Doxapram in addressing this critical challenge, offering insights into the complexities of respiratory support for these vulnerable infants.

Doxapram: A New Oasis for Respiratory Distress

The study sheds light on the potential of Doxapram as a respiratory stimulant for preterm infants experiencing apnea. This research offers a valuable contribution to the field of neonatal care, potentially expanding the options for managing this critical condition. While further investigation is necessary, the findings suggest that Doxapram could serve as a vital oasis in the desert of respiratory distress for preterm infants.

Navigating the Desert of Prematurity: A Guide for Parents

The study underscores the importance of early intervention and close monitoring for preterm infants, recognizing the delicate balance of their respiratory system. Like a caring desert guide, this research offers valuable insights for parents navigating the challenges of prematurity, providing a roadmap for navigating potential respiratory difficulties and seeking the best possible care for their infants.

Dr.Camel's Conclusion

Doxapram may offer a beacon of hope for preterm infants experiencing apnea, potentially expanding the options for managing this critical condition. The research emphasizes the importance of careful monitoring and seeking professional guidance for these vulnerable infants, offering valuable insights for navigating the complexities of their care.
Date :
  1. Date Completed 2023-10-26
  2. Date Revised 2023-11-03
Further Info :

Pubmed ID

37877431

DOI: Digital Object Identifier

PMC10598592

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.